“Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”

Detalles Bibliográficos
Autores principales: Rasmussen, Bengt, Göhring, Gudrun, Bernard, Elsa, Nilsson, Lars, Tobiasson, Magnus, Jädersten, Martin, Garelius, Hege, Dybedal, Ingunn, Grønbaek, Kirsten, Ejerblad, Elisabeth, Lorenz, Fryderyk, Flogegård, Max, Marcher, Claus Werenberg, Öster Fernström, Annette, Cavelier, Lucia, Papaemmanuil, Elli, Ebeling, Freja, Kittang, Astrid Olsnes, Nørgaard, Jan Maxwell, Saft, Leonie, Möllgård, Lars, Hellström-Lindberg, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061286/
https://www.ncbi.nlm.nih.gov/pubmed/35277655
http://dx.doi.org/10.1038/s41375-022-01537-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061286/
https://www.ncbi.nlm.nih.gov/pubmed/35277655
http://dx.doi.org/10.1038/s41375-022-01537-w

Ejemplares similares